The logo for the Alliance for Health Policy, with a blue and red triangle.

It's no secret that the practice of medicine is complex. Comparative effectiveness research (CER) has offered an approach to evaluate the outcomes of different healthcare methods and identify which treatments matter most to patients. Comparative effectiveness research has the potential to inform broader healthcare policy conversations on value, costs, and delivery system reform. This briefing, which was held on Capitol Hill in Washington, DC, informed attendees about the purpose and perspectives surrounding comparative effectiveness research, including how researchers conduct CER studies and how various stakeholders may utilize the results. Panelists also explored the current CER policy landscape.

This event was open to the public. Catch up with the conversation online: #AllHealthLive

Watch the Briefing


Alfiee M. Breland-Noble, PhD, MHSc
Project Director, African American Knowledge Optimized for Mindfully-Healthy Adolescents (AAKOMA)
Center for Trauma and the Community, Georgetown Medical Center

Project Lead: PCORI-funded Pipeline to Proposal Project

John Bulger, D.O., MBA
Chief Medical Officer, Geisinger Health Plan

Eleanor Perfetto, MS, PhD
Senior Vice President, Strategic Initiatives, National Health Council
Professor of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy

Project Lead: PCORI-funded Engagement Award ProjectPCORI-funded Engagement Award Project

Sean Tunis, MD, MSc
Founder and Senior Strategic Advisor, Center for Medical Technology Policy
Project Lead: PCORI-funded Engagement Award Project

Gail R. Wilensky, PhD
Senior Fellow, Project HOPE


Sarah J. Dash, MPH
President and CEO, Alliance for Health Policy